Charlier, Bruno
 Distribuzione geografica
Continente #
AS - Asia 3.045
NA - Nord America 1.256
EU - Europa 678
SA - Sud America 149
AF - Africa 24
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.161
Nazione #
HK - Hong Kong 2.261
US - Stati Uniti d'America 1.217
SG - Singapore 357
IT - Italia 275
CN - Cina 143
RU - Federazione Russa 127
VN - Vietnam 110
BR - Brasile 100
DE - Germania 61
FR - Francia 50
GB - Regno Unito 41
BD - Bangladesh 40
IN - India 37
CA - Canada 20
IE - Irlanda 20
FI - Finlandia 18
AR - Argentina 17
KR - Corea 17
PL - Polonia 17
MX - Messico 15
SE - Svezia 13
ES - Italia 12
JP - Giappone 11
EC - Ecuador 10
IQ - Iraq 10
NL - Olanda 10
PK - Pakistan 9
TR - Turchia 9
AT - Austria 8
AU - Australia 8
SA - Arabia Saudita 8
UA - Ucraina 8
ZA - Sudafrica 7
BE - Belgio 5
UY - Uruguay 5
CO - Colombia 4
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
SY - Repubblica araba siriana 4
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
PY - Paraguay 3
VE - Venezuela 3
CL - Cile 2
DZ - Algeria 2
GY - Guiana 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
MM - Myanmar 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TZ - Tanzania 1
Totale 5.161
Città #
Hong Kong 2.254
San Jose 196
Singapore 194
Dallas 153
Ashburn 113
Chandler 93
Naples 50
Princeton 50
Munich 47
Ann Arbor 45
Council Bluffs 39
Beijing 37
Los Angeles 34
Ho Chi Minh City 33
New York 33
Lauterbourg 27
Hanoi 22
Dublin 20
Salerno 19
Memphis 18
Dong Ket 17
Rome 17
The Dalles 17
Woodbridge 15
Moscow 14
Redwood City 14
São Paulo 14
Warsaw 14
Jacksonville 13
Mercato San Severino 13
Orem 13
Pune 13
Turku 13
Wokingham 13
Santa Clara 12
Stockholm 12
Fisciano 11
Seattle 11
Chennai 8
Houston 8
Montreal 8
Tokyo 8
Wilmington 8
Amsterdam 7
Brooklyn 7
Buffalo 7
London 7
Arba 6
Milan 6
Montpellier 6
Phoenix 6
San Prisco 6
Adelaide 5
Boardman 5
Denver 5
Francavilla Fontana 5
Guangzhou 5
Haiphong 5
Izmir 5
Johannesburg 5
Montevideo 5
Nuremberg 5
Palermo 5
San Francisco 5
Seoul 5
Tianjin 5
Valencia 5
Andover 4
Aversa 4
Brasília 4
Chicago 4
Glasgow 4
Guayaquil 4
Mexico City 4
Nairobi 4
Norwalk 4
Ottawa 4
Quito 4
Richmond 4
Rio de Janeiro 4
Shanghai 4
The Bronx 4
Toronto 4
Verona 4
Atlanta 3
Biên Hòa 3
Bologna 3
Caserta 3
Fairfield 3
Hebei 3
Helsinki 3
Jakarta 3
Manchester 3
Medina 3
Mumbai 3
Nanchang 3
Nanjing 3
Napoli 3
Novate Milanese 3
Poplar 3
Totale 4.012
Nome #
A UHPLC-MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers 788
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 581
Antioxidant Supplementation Hinders the Role of Exercise Training as a Natural Activator of SIRT1 423
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 249
Come rendere un ospedale formaldeide free 229
In Vitro Evaluation of Antibacterial and Antibiofilm Activity of Different Chlorhexidine-Containing Mouthwash Formulations against Streptococcus mutans 220
Standard addition method (SAM) in LC-MS/MS to quantify gluten-derived metabolites in urine samples 193
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 192
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 182
Chemical risk in hospital settings: Overview on monitoring strategies and international regulatory aspects 144
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease 136
Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples 127
Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples 126
Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood 121
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 119
Novel Drug Targets for the Treatment of Cardiac Diseases 118
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 117
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 117
Environmental and biological monitoring of formaldehyde inside a hospital setting: a combined approach to manage chemical risk in workplaces 111
Perampanel dosage in plasma samples: development and validation of a novel HPLC method with combined UV-Fluorescence detection 109
A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents 105
Lipid nano-vesicles for thyroid hormone encapsulation: A comparison between different fabrication technologies, drug loading, and an in vitro delivery to human tendon stem/progenitor cells in 2D and 3D culture 95
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications 93
Bioconversion of 4-hydroxyestradiol by extradiol ring-cleavage dioxygenases from Novosphingobium sp. PP1Y 92
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 88
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study 83
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain 81
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry 69
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 59
Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy 31
Long-Term Impact of Cenobamate on Cognition, Adaptive Behavior, and Quality of Life in Patients with Tuberous Sclerosis Complex 18
Catecholamines and Metanephrines: Quantification in the Diagnosis of Pheochromocytoma and Paraganglioma, Considerations and Critical Issues 6
Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications 4
Development, validation and real life applicability of new bioanalytical methods in the assessment and prevention of chemical risk in healthcare environments 1
Totale 5.227
Categoria #
all - tutte 14.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/202297 1 12 0 3 6 5 3 6 5 6 12 38
2022/2023249 15 33 37 32 17 40 6 18 30 0 6 15
2023/2024191 20 17 9 13 23 38 11 12 4 8 15 21
2024/2025536 4 12 9 16 37 42 121 30 77 23 67 98
2025/20263.863 138 1.359 1.036 185 233 74 236 77 145 245 98 37
Totale 5.227